Please sign in to follow a disease.
Can a simple screening and exercise plan keep RA patients moving?
NCT ID NCT06706999
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This pilot study tested whether a care model called PREVAIL is practical and acceptable for adults with rheumatoid arthritis. The model includes a screening tool to identify activity limitations, a recommendation to the rheumatologist for exercise or physical therapy, and an online exercise resource. Sixty-three participants completed the study, which measured how many received the key components and how they rated the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- PREVAIL model of care (screening tool, exercise website, and physical therapy consultation)
- What this could lead to
- If successful, this could provide a practical way to help people with rheumatoid arthritis maintain their daily activities and quality of life through better integration of rehabilitation into routine care.
- What could go wrong
- This is a small pilot study focused on feasibility, not on proving the model improves health outcomes. It may not work in other settings or for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
63 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Over the age of 18 * Clinician diagnosis of RA as defined by International Classification of Diseases 10 (ICD-10) code * Receiving routine care from a UNC rheumatology clinician * Have an upcoming scheduled visit with a UNC rheumatology clinician for a routine follow up Exclusion Criteria: * No documented diagnosis of RA * Under the age of 18 * Significant cognitive impairment * Condition that restricts ability to complete surveys and patient reported outcomes * Severe hearing or visual impairment * Serious/terminal illness as indicated by referral to hospice or palliative care * Unable to speak or read English * Current participation in any other study related to RA * Current or recent (within the last six months) participation in PT * Recent (within the last 6 months) major surgery requiring overnight hospital admission and/or resulting in functional loss, requiring rehabilitation * Upcoming (within the next 6 months) major surgery requiring overnight hospital admission and/or resulting in functional loss, requiring rehabilitation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthritis, rheumatoid (RA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Smartphone app aims to catch rheumatoid arthritis before it takes hold
- A patient questionnaire may rival lab tests for spotting rheumatoid arthritis flares
- Could fewer pills mean same relief for rheumatoid arthritis?
- Can a single cell therapy calm multiple autoimmune diseases?
- Heart risk in rheumatoid arthritis: could a blood vessel drug help?